- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/87 - HydrazidesThio or imino analogues thereof in position 3
Patent holdings for IPC class C07D 213/87
Total number of patents in this class: 40
10-year publication summary
|
1
|
4
|
4
|
2
|
1
|
5
|
3
|
2
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| HMI Medical Innovations, LLC | 16 |
8 |
| Theravance Biopharma R&D IP, LLC | 456 |
3 |
| F. Hoffmann-La Roche AG | 7947 |
2 |
| Bayer Cropscience AG | 2040 |
2 |
| The General Hospital Corporation | 4740 |
2 |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 84 |
2 |
| Monash University | 709 |
2 |
| University of Utah Research Foundation | 1810 |
2 |
| The Walter and Eliza Hall Institute of Medical Research | 165 |
2 |
| Mitsui Chemicals Agro, Inc. | 87 |
1 |
| Cytokinetics, Inc. | 279 |
1 |
| Eurofarma Laboratorios S.A. | 36 |
1 |
| Fudan University | 688 |
1 |
| Memorial Sloan-Kettering Cancer Center | 1931 |
1 |
| Musc Foundation for Research Development | 350 |
1 |
| Shandong University | 1048 |
1 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 829 |
1 |
| Shanghai Institute of Pharmaceutical Industry | 129 |
1 |
| Synta Pharmaceuticals Corp. | 174 |
1 |
| Universidade Federal do Rio de Janeiro-ufrj | 87 |
1 |
| Other owners | 4 |